Glenn Harris
Family Medicine · Laurinburg, NCNPI 1538245394
Payments from drug & device makers
Across 167 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$475
- AbbVie$430
- Esperion Therapeutics, Inc.$287
- Amgen$224
- AstraZeneca$202
- Pfizer$165
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,975100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 34 | $475 |
| AbbVie | 18 | $430 |
| Esperion Therapeutics, Inc. | 4 | $287 |
| Amgen | 23 | $224 |
| AstraZeneca | 13 | $202 |
| Pfizer | 11 | $165 |
| Abbott | 8 | $161 |
| Boehringer Ingelheim | 7 | $137 |
| Ardelyx, Inc. | 6 | $128 |
| Lilly USA, LLC | 6 | $115 |
| Exact Sciences | 5 | $91 |
| Johnson & Johnson | 5 | $80 |
| Novartis | 4 | $76 |
| Corcept Therapeutics | 4 | $72 |
| Phathom Pharmaceuticals, Inc. | 5 | $58 |
| Shield Therapeutics Inc | 1 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| GSK | 3 | $43 |
| Dynavax Technologies Corporation | 2 | $35 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $23 |
| Grifols USA, LLC | 1 | $21 |
| Si-bone, Inc. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Recordati_rare_diseases_inc. | 1 | $15 |
| Medtronic | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,975 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 224 | $224,284 |
| EliquisApixaban | 205 | $152,473 |
| JardianceEmpagliflozin | 127 | $115,910 |
| MounjaroTirzepatide | 97 | $107,266 |
| Repatha SureclickEvolocumab | 79 | $58,884 |
| FarxigaDapagliflozin Propanediol | 77 | $57,263 |
| XareltoRivaroxaban | 44 | $42,318 |
| RybelsusSemaglutide | 30 | $39,054 |
| Tresiba Flextouch U-100Insulin Degludec | 49 | $37,875 |
| JanuviaSitagliptin Phosphate | 28 | $36,851 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 81 | $36,727 |
| BriviactBrivaracetam | 13 | $36,273 |
| TrulicityDulaglutide | 30 | $32,294 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $17,628 |
| Victoza 3-PakLiraglutide | 16 | $13,934 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $475 | $263,338254 claims |
| PfizerEliquis | $165 | $152,473205 claims |
| Lilly USA, LLCMounjaro, Trulicity | $115 | $139,560127 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat, Combivent Respimat | $137 | $134,427165 claims |
| AstraZenecaFarxiga, Symbicort | $202 | $60,62492 claims |
| Johnson & JohnsonXarelto | $80 | $42,31844 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $43 | $29,52338 claims |
| AbbVieLinzess | $430 | $7,22711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Laurinburg
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
- Stephen JonesShelby$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.